Biotech Growth | Portfolio

Geographic breakdown

Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.

Data as at : 31/08/2021

Country % of total assets
USA 65.4
Ireland 8.2
China 7.3
Canada 4.5
Switzerland 2.6
Singapore 0.9
South Korea 0.8
France 0.8
Germany 0.7
UK 0.5
Netherlands 0.4

Asset breakdown

Data as at : 31/08/2021

Asset % of total assets
Stock 100.9
Other 1.2
Cash/Cash equivalents -2.1

Detailed asset breakdown

Asset % of total assets
North America - stock 73.7
Other - stock 9.2
Asia (excl Japan) - stock 9.0
Preferred stock 3.9
Europe - Mid-cap stock 2.3
UK - Small growth stock 1.6
Europe - Small-cap stock 1.2
Other 1.2

Industry breakdown

Data as at : 31/08/2021

Industry % of total assets
Healthcare 94.3
Preferred 3.9
Cash Equivalents -2.1

Top holdings

Data as at : 31/05/2021

Investment % of total assets
Vertex Pharmaceuticals Inc 6.1
Singular Genomics Systems Inc 4.3
Neurocrine Biosciences Inc 4.0
Horizon Therapeutics PLC 3.8
Alexion Pharmaceuticals Inc 3.2
Magenta Therapeutics Inc 3.1
Curis Inc 2.8
Aptose Biosciences Inc 2.8
Keros Therapeutics Inc 2.7
Other Assets And Liabilities -4.5

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.